WEI GUANGWEN has a total of 23 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CYTHERIS, ABBOTT LAB BERMUDA LTD and BAYERL THOMAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 1 | |
#4 | Republic of Korea | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Computer technology | |
#5 | Measurement | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Analysing materials | |
#6 | Computational chemistry | |
#7 | Fermentation | |
#8 | Syringes | |
#9 | Bioinformatics | |
#10 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Wei Guangwen | 23 |
#2 | Guo Rongbing | 2 |
#3 | Wang Dacheng | 2 |
#4 | Zhang Renhuai | 2 |
Publication | Filing date | Title |
---|---|---|
US2012316322A1 | Design and use of new recombinant interferons with altered spatial configuration and three-dimensional structure | |
US2012308520A1 | Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof | |
US2011070195A1 | Uses of spatial configuration to modulate protein function | |
US2009123417A1 | Treatment of tumors and viral diseases with recombinant interferon alpha | |
KR20070108904A | Uses of recombinant super-compound interferons | |
US2006035327A1 | Recombinant super-compound interferon and uses thereof | |
US7585647B2 | Nucleic acid encoding recombinant interferon |